NCT07712406 Ultrasound-Guided Proximal Superior Cluneal Nerve Block for Superior Cluneal Nerve Entrapment
| NCT ID | NCT07712406 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gaziosmanpasa Research and Education Hospital |
| Condition | Superior Cluneal Nerve Entrapment |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-05-15 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2026-05-15 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Superior cluneal nerve entrapment (SCNE) is an underrecognized cause of chronic low back pain and gluteal pain that may mimic lumbar spine disorders. Ultrasound-guided proximal superior cluneal nerve block has increasingly been used in routine clinical practice .Diagnostic superior cluneal nerve block is commonly used to confirm the diagnosis, whereas ultrasound-guided proximal superior cluneal nerve block has emerged as a therapeutic option. This prospective observational cohort study aims to evaluate the clinical outcomes of ultrasound-guided proximal superior cluneal nerve block in patients with clinically diagnosed superior cluneal nerve entrapment who undergo the procedure as part of routine clinical care. Pain intensity, disability, and neuropathic pain characteristics will be assessed at baseline and during follow-up to evaluate treatment outcomes.
Eligibility Criteria
Inclusion Criteria: * Age 18-75 years. * Chronic low back and/or gluteal pain persisting for at least 3 months. * Localized pain and/or tenderness over the posterior iliac crest. * At least 50% reduction in pain intensity following diagnostic superior cluneal nerve block. * Failure of conservative treatment. * Ability to provide written informed consent. Exclusion Criteria: * Previous superior cluneal nerve surgery. * Active local or systemic infection. * Bleeding disorders or contraindications to the procedure. * Allergy to study medications. * Pregnancy. * Severe cognitive impairment or inability to complete study assessments. * Additional interventional pain procedures involving the affected region during follow-up.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07712406 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Superior Cluneal Nerve Entrapment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07712406 currently recruiting?
Yes, NCT07712406 is actively recruiting participants. Contact the research team at tugceyavuz@hotmail.com.tr for enrollment information.
Where is the NCT07712406 trial being conducted?
This trial is being conducted at Gaziosmanpaşa, Turkey (Türkiye).
Who is sponsoring the NCT07712406 clinical trial?
NCT07712406 is sponsored by Gaziosmanpasa Research and Education Hospital. The trial plans to enroll 40 participants.